Fortress Biotech Inc. (FBIO) Stock has dropped down in the After-Market: What’s happening?
Fortress Biotech, Inc. (FBIO) a leading biopharmaceutical company specializing to acquire, develop and commercialize potentially viable biopharmaceutical products and product candidates at low cost, announced financial report for the first quarter completed on March 31, 2021. FBIO stock price decreased adjacent to the news. At last check in after-market trading, shares of Fortress Biotech Inc. […]